JPMorgan raises Qiagen target from USD 50 to USD 55 for Qiagen stock

Published on 10/16/2026 at 10:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Qiagen reported Q2 revenue of USD 535.04 million and adjusted EPS of USD 0.62. Q3 results for Qiagen stock arrive November 3, 2026.

Recent catalysts and dates

JPMorgan lifted its Qiagen target from USD 50 to USD 55 on October 14, 2026.
Qiagen reported second-quarter revenue of USD 535.04 million and adjusted earnings per share of USD 0.62.
Qiagen stock traded at EUR 41.33 at 10:41 a.m. CEST at Lang & Schwarz on October 16, 2026.

Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte, klinisches Laborlicht — Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

Qiagen (ISIN NL0015002SN0) drew a JPMorgan target increase from USD 50 to USD 55 on October 14, 2026, according to Business Insider. The revision gives the analyst call more weight ahead of Qiagen's third-quarter report.

Target rises ahead of results

JPMorgan kept an Overweight rating while raising the target from USD 50 to USD 55. The change was reported on October 14, 2026, and provides a clear valuation reference in US dollars rather than a euro price for the German quotation.

The latest completed operating period was the second quarter of 2026. Qiagen generated USD 535.04 million in revenue and adjusted earnings per share of USD 0.62, compared with consensus earnings per share of USD 0.5980, according to MarketBeat.

What does the next report test?

MarketBeat lists November 3, 2026, for Qiagen's third-quarter results and November 4, 2026, for the conference call. Its estimate is USD 535.61 million in revenue and USD 0.6210 in earnings per share, versus USD 532.58 million and USD 0.6421 in the year-earlier quarter. That comparison points to expected revenue growth of 0.57 percent and lower earnings per share.

Ownership adds a second signal

A voting-rights disclosure dated October 14, 2026, reported that BlackRock held 12.72 percent of Qiagen's voting rights. The disclosure identified a transaction date of October 7, 2026, and was carried by TradingView.

Euro quote and reporting dates

For investors using the German listing, the next hard test is the November reporting date. Qiagen was trading at EUR 41.33 at Lang & Schwarz on October 16, 2026 at 10:41 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Qiagen stock.